nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2023, 01, v.6 71-74
益肾通络方对早中期慢性肾功能衰竭的疗效
基金项目(Foundation): 梅州市中医药科研项目(No:2020-B-68)
邮箱(Email):
DOI:
发布时间: 2023-03-28
出版时间: 2023-03-28
移动端阅读
摘要:

目的:采用益肾通络方治疗早中期慢性肾功能衰竭患者,验证其有改善肾功能、延缓疾病进展方面的疗效。方法:本研究共纳入120例早中期慢性肾功能衰竭患者,随机分为治疗组和对照组,每组各60例。对照组采用纯西医药物治疗,治疗组在对照组治疗的基础上,加用益肾通络方。所有患者规律治疗1个月。治疗前后监测尿素氮(BUN)、血肌酐(Scr)及肾小球滤过率(GFR)变化。结果:经治疗后,治疗组的BUN、Scr、GFR均明显优于对照组(均P<0.05)。治疗组治疗总有效率为50.00%,明显高于对照组26.67%(P<0.05)。结论:益肾通络方联合西医基础治疗能显著降低早中期慢性肾功能衰竭患者的BUN和Scr,提高GFR,延缓肾功能恶化。

Abstract:

Objective: Tonifying kidney and dredging collaterals prescription is used in the treatment of patients with early and middle stage chronic renal failure. This article aims to verify the efficacy of tonifying kidney and dredging collaterals in improving renal function and delaying disease progression. Methods: A total of 120 patients with early and middle stage of chronic renal failure were enrolled and randomly divided into the treatment group and the control group, with 60 cases in each group. The control group were treated with pure Western medicine, while the treatment group were treated with tonifying kidney and dredging collaterals prescription in addition to the Western medicine. All patients were regularly treated for one month. Blood urea nitrogen(BUN), serum creatinine(Scr) and glomerular filtration rate(GFR) were monitored before and after treatment. Results: Compared to the control group, BUN, Scr and GFR in the treatment group were significantly better(all P<0.05). The effective rate was 50.00% in the treatment group, which was significantly higher than 26.67% in the control group(P<0.05). Conclusion: Tonifying kidney and dredging collaterals prescription combined with Western medicine can significantly reduce Scr and BUN, increase GFR and delay the deterioration of renal function on early and middle stage of chronic renal failure.

参考文献

[1] 白雪莲,张佳宜,项国梁,等.中国成人慢性肾脏病患病率的meta分析[J].中国医药科学,2022,12(9):49-53.

[2] Hsu C Y,Vittinghoff E,Lin F,et al.The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency[J].Ann Intern Med,2004,141(2):95.

[3] 张晓文,袁玮,钱雅玉.基于数据挖掘探讨于、孙氏学术流派治疗慢性肾衰竭用药规律[J].山西中医药大学学报,2020,21(2):135-139.

[4] 吴中繁,李晨,孔薇.孔薇教授治疗慢性肾衰竭的经验[J].福建中医药,2021,52(2):45-46.

[5] 林成锦,吴强,石伟荣,等.吴强主任医师运用补肾祛毒汤治疗慢性肾衰竭经验探析[J].亚太传统医药,2021,17(4):96-99.

[6] 张冰冰,鲁科达,张培培,等.消瘀泄浊饮对慢性肾衰竭动脉粥样硬化大鼠主动脉泛素-蛋白酶体通路组分表达的影响[J].中国中医药科技,2021,28(6):876-880.

[7] 刘超,王银平,朱小亮,等.益气化瘀通腑法治疗早中期慢性肾脏病的临床研究[J].现代中西医结合杂志,2021,30(20):2203-2206.

[8] 冯培云,刘冰冰,张守琳.赵振昌教授以瘀立法治疗慢性肾衰经验[J].中国中医药现代远程教育,2017,15(6):64-66.

[9] 郑筱萸.中药新药临床研究指导原则[M].中国医药科技出版社,2002.

[10] 林果为,王吉耀,葛均波.《实用内科学》第1~15 版[J].科技与出版,2017(12):2.

[11] 丁国明,戢晴,韩颖敏.山茱萸提取物对慢性肾功能衰竭大鼠的肾保护作用及对oxidase/ROS/ERK信号通路的影响[J].新中医,2020,52(18):14-18.

[12] 孙要军,要慧子,姚瑶,等.巴戟天寡糖对肾性高血压大鼠预后的影响及其机制研究[J].中国药物与临床,2021,21(16):2767-2769.

[13] 颜春鲁,安方玉,刘永琦,等.黄芪总苷对氯化镉染毒大鼠肝肾损伤的保护作用[J].毒理学杂志,2018,32(4):292-295.

[14] 杨茹茜.黄芪甲苷基于Toll样受体通路对肾纤维化的作用研究[D].泸州:西南医科大学,2018.

[15] 马晓晴,王捷,胡君萍,等.肉苁蓉苯乙醇总苷对庆大霉素诱导急性肾损伤大鼠的药效学研究[J].新疆医科大学学报,2020,43(7):942-946.

[16] 田乙玲.基于Nrf2/HO-1信号通路探讨山药-白茅根“药对”对造影剂肾病大鼠氧化应激的影响[D].长沙:湖南中医药大学,2020.

[17] 张术姣,谭小月,张勉之.丹参提取物对顺铂诱导小鼠急性肾损伤的影响及机制研究[J].中华中医药杂志,2021,36(12):7324-7328.

[18] 靳贺超,梁胜然,张冠文,等.基于TXNIP/NLRP3/GSDMD信号通路探讨当归补血汤对糖尿病肾病大鼠足细胞焦亡的影响[J].中国实验方剂学杂志,2022,28(3):49-57.

[19] 霍易飞,高诗慧,杨宇峰,等.红花治疗糖尿病肾病网络药理学研究[J].辽宁中医药大学学报,2020,22(12):118-124.

[20] 姜宣羽,王思为,钟松阳,等.土茯苓总黄酮对Lewis肺癌小鼠顺铂化疗肾损伤的影响[J].中药材,2019,42(9):2163-2167.

[21] 张瑞芳,许艳芳,万建新,等.泽泻对单侧输尿管梗阻大鼠肾组织补体C3及肾纤维化的影响[J].中国中西医结合肾病杂志,2012,13(8):672-674.

基本信息:

中图分类号:R277.5

引用信息:

[1]陈杏浩,骆敏芳.益肾通络方对早中期慢性肾功能衰竭的疗效[J].巴楚医学,2023,6(01):71-74.

基金信息:

梅州市中医药科研项目(No:2020-B-68)

发布时间:

2023-03-28

出版时间:

2023-03-28

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文
检 索 高级检索